1

CURRICULUM VITAE

Barbara J. StruppProfessor

Division of Nutritional Sciences& Department of Psychology

Cornell UniversityIthaca, NY

ADDRESS TELEPHONEDivision of Nutritional Sciences Work: (607) 255-2694& Department of Psychology Home: (607) 272-5122Cornell University FAX: (607) 255-1033217 Weill Hall 109 Savage Hall Ithaca, NY 14853

EDUCATIONWashington University Ethology, B.A., 1976

(Leeds University, Leeds, England, 1975-1976)

Cornell University, Biopsychology, Ph.D., 1982Minor concentrations: physiology, endocrinology and animal behavior

National Institutes of Health (National Institute of Mental Health) Postdoctoral Fellow, 1981-1983

PROFESSIONAL EMPLOYMENT

2007-present Professor, Division of Nutritional Sciences and Adjunct Professor, Department of Psychology, Cornell University

1993-2007 Associate Professor, Division of Nutritional Sciences and Adjunct Associate Professor, Department of Psychology, Cornell University

1989 - 1993 Senior Research Associate, Division of Nutritional Sciences and Adjunct Assistant Professor, Department of Psychology, Cornell University

1983 - 1989 Research Associate, Division of Nutritional Sciences, Cornell University

1981 - 1983 Postdoctoral Fellow, Biological Psychiatry Branch, National Institutes of Health, Bethesda, Maryland

1977 - 1981 Teaching Assistant, Department of Psychology, Cornell University

FELLOWSHIPS, HONORS, AND AWARDS

2

Elected to Phi Beta Kappa, 1976 Awarded Sage Fellowship for Graduate Studies, Cornell University, 1976 NIH Postdoctoral Fellowship, 1981-1983 Awarded NIH New Investigator Research Award, 1983 Secretary, Neurobehavioral Teratology Society, 1992-1994 (elected office)Published article selected by QUINTESSENCE, Excellence in Environmental

Contamination and Toxicology, as an example of excellence in this field, 1994 Editorial Board of Neurotoxicology and Teratology, 1995-1997, 1999-2011Council member, Neurobehavioral Teratology Society (elected office), 2008-2011Awarded the 2011 Centrum Center Award by the American Society for Nutrition (ASN); This award is

given for recent investigative contributions of contemporary significance to the understanding of human nutrition.

Nominated for Cornell /CHE KON/Alumni Advising Award, 2015Awarded the Kendall S. Carpenter Advising Award for excellence in Advising, Cornell University,

2015

TEACHING AND ADVISING RECOGNITION

Nominated for the "Paramount Professor Award" by the Cornell Panhellenic and Interfraternity Councils, Cornell University, 1992, 1995, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010.

Invited to the “400 Club Breakfast”, Cornell University, 2003, 2005, 2006, 2014, 2015, 2016 (Student athletes with a 4.0 GPA are invited to have breakfast with the President and invite the one professor that has had the most significant impact on his/her Cornell education)

Acknowledged by a Merrill Presidential Scholar as the Cornell faculty member who most significantly contributed to his college experience: 2014 (Merrill Presidential Scholars rank among the top one percent of the class in their respective schools and colleges. Each scholar is given an opportunity to recognize the Cornell faculty member who most significantly contributed to his or her college experience.)

Nominated for the Cornell /CHE KON/Alumni Advising Award, 2015Awarded the Kendall S. Carpenter Advising Award for excellence in Advising, Cornell University, 2015

RELATED PROFESSIONAL ACTIVITIES

Public Advisory Groups, Expert Panels, etc.

International Dietary Energy Consultative Group (IDECG) Task Force on the Effects of Protein-Energy Malnutrition on Behavioral Development, Invited Participant, Dec.6-10, 1993, Davis, CA.

External Advisory Committee, NIH Center grant on Children’s Environmental Health, entitled, “FRIENDS (Fox River Environment & Diet Study) Children’s Environmental Health Center at University of Illinois, Champaign-Urbana”; S. Schantz, PI., 2001-2006.

External Advisory Committee, NIH Program Project grant, entitled, “Brain and Behavior in Early Iron Deficiency”, B. Lozoff, PI, 2003-2013, Chair, 20012-2013.

Member, National Institutes of Health Reviewers Reserve (NRR), July 1, 1994 - June 30, 1998.

3

NIH Study Section participant in Special Review Committees, Site visits, and Ad hoc reviews:

Member, Pharmacology I Study Section, Drug Abuse Biomedical Research Review Committee of the National Institute on Drug Abuse (NIDA), National Institutes of Health, 1992 - 1994.

Multi-Institute RFA (Fogarty Center, NINDS, NICHD, NIEHS, NIMH, etc)Special Review Committee, RFA on “Brain Disorders in the developing world: Research across

the life span”, August 2003

National Institute on Child Health and Human Development (NICHD)Special Review Committee, 1995, 2004 (invited)Special Review Committee, Applicant Interview, 1996 Site Visit team, 1997 (invited), 1998 (invited), 2000Special Review Committee, RFA on Down Syndrome, 1998

Mental Retardation Study Section, 1997, Invited to be a member (deferred for now). Mental Retardation Research Subcommittee, Ad hoc reviewer, 1999, 2000, 2001 (invited), spring

2004 (invited), Fall 2004 (invited), Special Review Committee, RFA entitled, “Autism Centers of Excellence (P50)”, November,

2006.Special Review Committee AR 06-053/ Interdisciplinary Developmental Science Centers for

Mental Health (IDSC): Mature Centers or PAR 06-062/Interdisciplinary Developmental Science Centers for Mental Health (IDSC): Formative Centers dealing with autism and repetitive behaviors, July, 2007;

Special Review Committee, Intellectual and Developmental Disabilities Research Centers [RFA-HD-08-016], March 23-24, 2009;

Special Emphasis Panel: Review of a P01 Application, July 26, 2010.Special Emphasis Panel to review P30 applications in response to RFA-HD-10-022: Intellectual

and Developmental Disabilities Research Centers (IDDRC) 2011; June 29-30, 2011 (invited); July 25-26, 2016 (invited)

Special Review Committee to review a P01 application, Dec. 10, 2014.

National Institute on Environmental Health Sciences (NIEHS)Site visit team, 1997 (invited) Special Review Committee, RFA on “Centers for Children’s Environmental Health and Disease

Prevention Research”, March 1998, March 2001; August 2003 (invited)Environmental Health Sciences Review Committee, Ad hoc reviewer, July 2000Special Review Committee, RFA on “The Fetal Basis of Adult Disease: Role of the

Environment”, November, 2002 (invited)Special Review Committee, RFA entitled, “Interdisciplinary Partnerships in Environmental

Health Sciences”, May, 2006 (invited)Special Review Committee to review P42 applications as part of the Superfund Basic Research

Program (SBRP), September, 2007 (invited), October 2013 (invited)Special Review Committee, RFA on "Centers for Children's Environmental Health and Disease

Prevention Research (RFA-ES-14-002)", May 10-12, 2015 (invited). 

National Institute on Drug Abuse (NIDA)Pharmacology I Study Section, 1991, Ad hoc reviewerBiochemistry Study Section, 1994, Ad hoc reviewerSpecial Review Committee, NIDA RFA entitled "Consequences of Marijuana use on the

Developing Brain" (RFA-DA-04-016), August, 2004 (invited)

4

NIDA Training and Career Development Review Committee, Ad hoc reviewer, March 2006 (invited)

National Cancer Institute (NCI)Special Review Committee, “Small Grants (RO3) for Behavioral Research in Cancer

Control”, June 7, 2012 (invited).

National Institute of Mental Health (NIMH)Special Review Committee, reviewed grants submitted in response to PAR 06-053/Interdis-

ciplinary Developmental Science Centers for Mental Health (IDSC): Mature Centers or PAR 06-062/Interdisciplinary Developmental Science Centers for Mental Health (IDSC): Formative Centers dealing with autism and repetitive behaviors, July, 2007.

Special Review Committee, “Interdisciplinary Developmental Science Centers” grants (ZMH1 ERB-C-09), to review applications submitted in response to PA 06-062 (Formative P20 Centers) or PA -6-053 (Mature P50 Centers), July 2008 (invited).    

The National Institute on Deafness and Other Communication Disorders (NIDCD) Fellowship review on Voice, Speech and Language; February 5 2015 (invited).

Inter-Institute Study sections

Brain Disorders and Clinical Neuroscience-2 (now CNNT), Ad hoc reviewer, 2004 (invited) Developmental Biology Subcommittee, Ad hoc reviewer, 2004 (invited); June 2005 (invited)Biobehavioral Regulation, Learning & Ethology (BRLE) SRG, Ad Hoc Reviewer, 2004 Brain Disorders & Clinical Neurosciences Study Section, Temporary Member, June 2005Alcohol and Toxicology Subcommittee, Ad hoc reviewer, Dec. 2007 (invited)Developmental Brian Disorders (DBD) study section, Temporary Member, October, 2008

(invited); June 2012 (invited); October 25-26, 2012.IFCN-C (03) Special Emphasis Panel: Neuroendocrinology and Fetal Alcohol, July 2010

(invited)IFCN-C (02) M Special Emphasis Panel:  Memory, Stress, Pain and Alcohol, Member,

December 1-2, 2010IFCN-C (02) M Special Emphasis Panel:  Drugs and Alcohol. Neuroendocrinology,

Neuroimmunology, Rhythms and Sleep (NNRS) Study Section, Integrative, Functional and Cognitive Neuroscience IRG. September, 2013 (invited)

IFCN-C (02) M Special Emphasis Panel: Alcohol and Drugs, January 2014 (invited)ZRG1 BBBP-V (57) Meeting, review applications submitted for PAR13-195 – “Preclinical

Research on Model Organisms to Predict Treatment Outcomes for Disorders Associated with Intellectual and Developmental Disabilities”, February 2014, June 2015, March 2016 (invited), October 2016.

Alcohol and Toxicology Subcommittee 3 (ALTX-3), National Institutes of Health, Invited to be considered for membership in 1997 and 2000 (deferred).

Brain Disorders and Clinical Neuroscience 5 Study Section (BDCN-5), 1998, Invited to be a member (deferred)

5

Other Grant Review and Editorial Responsibilities

Editorial Board, Neurotoxicology and Teratology, 1996-1999, 1999-2011

Ad hoc reviewer for grant proposals submitted to:NSF, sections on:

PsychobiologyMemory and Cognitive ProcessesBehavioral Neuroendocrinology

USDAUniversity of Wisconsin-Madison, Environmental Health Sciences Center for

Developmental and Molecular ToxicologyOntario Mental Health FoundationCornell University: Human Ecology Seed & Innovation Awards for Experienced FacultyIWT (research funding & innovation stimulation agency of the Belgian government) Department of Veterans Affairs, Gulf War Illnesses/Military Environmental Exposures,

Office of Research and Development (10P9)EU Joint Programming Initiative, "Nutrition and Cognitive Function - Call for Joint

Transnational Research Proposals", review panel, September 9-10, 2015 in Vienna, Austria, organised by the NutriCog Joint Call Secretariat at PT-DLR (Invited).

Ad hoc reviewer for manuscripts submitted to:American Journal of Clinical NutritionAmerican ZoologistBehavioral NeuroscienceBehavioural Brain ResearchBrain ResearchDevelopmental Psychobiology Environmental Health PerspectivesEnvironmental ResearchGenes, Brain and Behavior Infant Behavior and Development Journal of NeuroscienceJournal of NutritionJournal of Comparative Psychology Life SciencesNeurotoxicologyNeurotoxicology and TeratologyPharmacology, Biochemistry, and BehaviorPhysiology and BehaviorPsychological BulletinPsychopharmacologyScienceToxicological Sciences

P articipation in Professional Organizations

Neurobehavioral Teratology Society, MemberSecretary (elected office), June 1992 - June 1994

6

Council (elected office), June 2002-June 2005, June 2008-2011 Publications Committee (elected office), June 1995 - June 1998Nominations Committee, June 1998 – June 2001, Chair, 2000-2001Finance Committee, Co-Chair, 1990-1991Membership Committee, 1991-1992Constitution and Bylaws Committee, 2012-2014, Chair 2013-2014

Society for Neurosciences, MemberSociety of Toxicology, Member

University Service

Member, Search Committee for Senior Administrator, Division of Nutritional Sciences, January - February, 1993

Animal Care Committee, Division of Nutritional Sciences, Member: 1986-1988, 1993-2006Chair, 1996-1999, 2004-2006

Faculty Advisor for Psi Chi (Student Honors Society), Department of Psychology, 1991-1993

Harassment Advisor, College of Human Ecology, 1991-1996.

Member, Committee on Affirmative Action, Cornell University, July 1994 - June 1997, elected office.

Member, Search Committee in the Division of Nutritional Sciences, to hire a new faculty member in the field of Human Metabolism, Fall '94 - Fall ’95.

Member, Search Committee in the Division of Nutritional Sciences, to hire a new faculty member who will be Head of the Dietetics Program, 1995 - 1996.

Member, Nominations Committee, Graduate Field of Nutrition, 1995-1998

Member, TA Recognition Committee, Department of Psychology, 1995-1997

Member, Curriculum Committee, Division of Nutritional Sciences, 1995-1996.

CALS Curriculum Committee, 1996-1997

Member, Faculty Interview Team for DNS Financial Manager, Division of Nutritional Sciences, November 1996

Member, Task Force to consider the teaching of Ethics in the CALS Curriculum, 1997.

Member, Admissions Committee, Graduate Field of Toxicology, 1997-1999

DNS representative to the Faculty Senate, 1997-1999, elected office.

CALS Registrar Advisory Committee, 1997- ?? (indefinite term)

7

Member, Search Committee for Clinical Veterinarian, CRAR, Cornell University, February - May 1998

DNS Animal Welfare Committee, 1996- 2006, Chair 1998-1999, 2003-2006

DNS Research Committee, Member, 1998-2001; Chair, 2000-2001

Invited Speaker and panel participant, New Faculty Development Program, Resource Panel: “Tips on starting as a new professor”, Ithaca, NY, October 12, 1998.

DNS Drug Control Officer (Savage Hall), 1999-present

Member, Search Committee for Director of the Cornell Mammalian Genomics Program, Cornell University, Fall 1999 – Spring 2000.

Member, Search Committee for Mammalian Genomics position, Department of Biomedical Sciences, Veterinary College, Cornell University, Fall 1999 – Spring 2000.

Chair, Committee to evaluate the appointment of Dr. Patricia Cassano to Assistant Professor, Division of Nutritional Sciences, Cornell University, Fall 1999.

Invited Speaker, College Scholar Program in Human Ecology, Cornell University, March 13, 2000.

Member, Mammalian Genomics Thrust Committee, Cornell University, June 2000 – December 2002.

Member, Committee to advise the Director on Genomics Faculty Searches, Division of Nutritional Sciences, Summer 2000.

Academic Affairs Committee, Graduate Field of Nutrition, Member, 2001-2004.

Admissions Committee, Graduate Field of Nutrition, Member, 2002-2004.

Member, Search Committee for Faculty positions in Genomics (three positions), Division of Nutritional Sciences, Cornell University, 1999 – 2001.

Faculty Co-Investigator pursuant to Policy 6.4 (Sexual Harassment), June 2003-present

Member, TA Recognition Committee, Division of Nutritional Sciences, 2000-2003

Chair, Ad Hoc Committee to evaluate the promotion and tenure of Dr. Qi Wang, Cornell University, Spring 2005.

Member, Curriculum Committee, Field of Environmental Toxicology, 2005-2010

Member, Search Committee for an assistant professor with research interests in psychopathology, personality (possibly from a genomics perspective), or health psychology, Department of Psychology, Fall 2005-Spring 2006.

8

Member, Task Force to evaluate the teaching of Undergraduate Biology, University-wide task force, January 2007-2009

Academic Affairs Committee, Graduate Field of Nutrition, Member, 2007-2010

Member, Emeritus Space Committee, Division of Nutritional Sciences, 2008-2011

Faculty partner, The Human Ecology Peer Partnership Program for disadvantaged freshman, Cornell University, 2009. 

Member, Animal Care and Use Program Advisory Committee, University-wide advisory group, June 2010- January 2011.

Member, Curriculum Committee, Division of Nutritional Sciences, 2011-2014 (Acting Chairperson, Spring 2013), 2015-2018

Member, search committee for the CARE Director/Attending Vet position, Cornell University, June 2011-March 2012

Faculty advisor for MEDLIFE, an organization of students interested in MEDLIFE, an international organization created to help low-income families achieve greater freedom from the constraints of poverty, empowering them to live healthier lives. MEDLIFE aims to achieve this goal through partnering with motivated individuals in poor communities working to improve their access to MEDs: Medicine, Education and community Development. 2012-present.

Member, Ad Hoc Committee advising Dean Boor on the tenure of  Dr. Lori Leonard, Cornell University, January-February 2014

Faculty advisor for HOSA, a student organization…. (fill in info about HOSA); January 2014- present.

Faculty advisor for Alzheimer awareness group, a student organization ….: January 2014- present

Letter-writer for HCEC (Health Careers Evaluation Committee), 2013, 2014

Appointments and Tenure Committee, Division of Nutritional Sciences, Cornell University, 2014-17; Co-Chair, 2014-2015; Chair, 2015-2016;

Faculty Advisor for “I am that Girl”, a student organization …..(fill in details); Sept 2014 – present

Life Sciences Advisory Council (LSAC), member, 2014-2017

Interim Director of Undergraduate Studies, Division of Nutritional Sciences, Cornell University, January –June, 2015.

Experiential Learning Committee, Division of Nutritional Sciences, Cornell University, January-June 2015

9

Director of Graduate Studies, Field of Nutrition, Cornell University, January 2016-August 2018.

Member, Committee to select the winners of the Kendall S. Carpenter Advising Award for excellence in Advising for 2016, April 2016

Mentor, Cornell Teaching Partnership Program, Cornell Univeristy, June 2016-present.

Public Service

Member, Lead Poisoning Prevention Task Force; a local group working on community issues relating to lead poisoning, 1996-2000, comprised of individuals from the Health Department, Cooperative Extension, the County Board of Representatives, the Tompkins-Cortland Labor Coalition, public health professionals, and an occupational hygienist.

Member, Tompkins-Cortland Labor Coalition Health and Safety Advisory Board, 1992 – 1995.

RESEARCH SUPPORT

Grants Awarded

Principal Investigator, “Beneficial Effects of Increased Maternal Choline Intake on Child Cognition & Temperament”, NY State Hatch funds, CSREES, SPF ID ??:, NYC-1007195, $30,000/yr, Oct 2015-Sept 2018. Co-Investigator, “Function of TMEM106B in Neurodegeneration”, National Institutes of Health (NINDS), NIH R01 NS088448-01; 8/1/2014-7/30/2019. $218,750/year direct cost.

Co-Investigator (PI of Subcontract), “Neurobehavioral impacts of early Mn exposure”, National Institutes of Health (NIEHS), 1R01ES018990, 6/1/10 – 5/31/17; Cornell subcontract: $76,781/yr. Principal Investigator, “Perinatal choline therapy in a mouse model of Down syndrome and Alzheimer’s Disease”. National Institutes of Health (NICHD), 1R01HD057564-01, 2/15/08 – 1/31/14, $2,982,700.

Co-Investigator, “Lasting effects of prenatal and early postnatal choline supplementation on cognitive development during infancy and early childhood”. Bronfenbrenner Life Course Center, Cornell University. 7/1//2010 - 6/30/2011. $8,500.

Principal Investigator, “Optimal Choline Intake Early in Life for the Prevention of Aging-Related Cognitive Decline”, Hatch, CSREES, SPF ID: 3110006036 NYC-199426, $25,000/yr, Oct 2007-Sept 2009.

Project Director of subcontract, “Attentional function in the Ts65Dn mouse: Elucidation of the dysfunction and potential amelioration by prenatal choline supplementation.” National Institutes of Health (NICHD), 3/1/03-2/28/08, Direct costs of subcontract (annual average):

10

$38,000. [subcontract from: RO1 HD45224 , “Behavioral analysis of a Mouse model of Down syndrome" (L. Crnic, PI)]

Principal Investigator, “Prenatal Cocaine Exposure and Attentional Dysfunction”, National Institutes of Health (NIDA), 1 RO1 DA/HD13965, 4/01/02 – 3/31/07 (No-cost extension until Feb 2009), Total Direct Costs: $2,252,103.

Project Director of subcontract, “Attentional function in the Ts65Dn mouse.” National Institutes of Health (NICHD), 01/01/02 - 12/31/03 Direct costs of subcontract $58,800. [Part of project 7, one project in a program project grant (Patterson, PI), PO1 HD17449, entitled, “Somatic Cell Genetic Studies of Down Syndrome "]

Project Director, "Enduring Cognitive Effects of Prenatal Deficiency of Folate and/or Iron: A Murine Model," USDA/CSREES, 9/1/99 to 8/31/02, my project: $110,032. [One project in a program grant (J. Haas, PI) "Integration of Nutritional Goals and Food Systems."]

Co-Investigator, "Developmental Neurotoxicity of Cocaine: An IV Rat Model" (C.F. Mactutus, PI, University of Kentucky); National Institutes of Health (NIDA), 2/1/99-1/31/02, Direct costs $551,741, Total costs $746,971, subcontract to BJS, $132,840 (Direct Costs).

Principal Investigator, "DMSA: Efficacy in Reducing Neurobehavioral Toxicity of Lead", National Institutes of Health (NIEHS), April 1995 - March 2002, Direct Costs Awarded: $949,253.

Principal Investigator, "DMSA: Efficacy in Reducing Brain and Tissue Lead", National Institutes of Health (NIEHS), June 1997 - May 2001, Direct Costs: $591,006 (peer-reviewed supplement to the above grant).

Project Director, "DMSA: Efficacy in Reducing Neurobehavioral Toxicity of Lead", National Institutes of Health (NIEHS), April 1995 - March 2002, Direct Costs awarded: $926,240; one project in a program grant entitled, “Cornell Superfund Basic Research Program”(J. Gillette, PI).

Principal Investigator, "Enduring Effects of Developmental Cocaine Exposure, National Institutes of Health (NIDA), February 1994 - January 1998, Direct Costs: $302,665.

Co-Investigator, “Maternal Biorhythms and Neonatal Neurologic Integrity”, (P. Nathanelsz, PI), National Institutes of Health (NINDS), April 1995 - February 1999, Direct costs: $795,492.

Project Director, "Factors Modifying Behavioral Toxicity of Lead and PCBs". National Institutes of Health. April 1992 - March 1995, Direct Costs: $320,098; one project in a program grant entitled, "Cornell Superfund Basic Research Program".

Principal Investigator, "Factors Modifying Behavioral Toxicity of Lead and PCBs". March of Dimes Birth Defects Foundation, March 1992 - October 1994, Direct Costs: $36,364.

Principal Investigator, "Enduring Cognitive Effects of Early Cocaine Exposure". March of Dimes Birth Defects Foundation, March 1992 - February - 1994, Direct Costs: $35,277 (awarded but could not accept).

Principal Investigator, "Neonatal biochemical disturbances and adult cognition". National Institutes of Health. October 1988 - August 1992. Direct Costs: $384,002.

11

Principal Investigator, "Factors Modifying Behavioral Toxicity of Lead and PCBs". New York State Hatch Project. October 1991 - September 1992. Direct Costs $6,000.

Principal Investigator, "Neonatal hyperphenylalaninemia: A tool for the study of early biological insults on cognition". March of Dimes Birth Defects Foundation. March 1987 - February 1989. Direct Costs $66,553.

Co-Investigator, "Reducing dietary fat: effect on weight and food intake". National Institutes of Health. July 1987 - June 1989. Direct Costs $107,237.

Co-Investigator, "Reducing dietary fat". Best Foods. Duration January 1988 - December 1989. Direct Costs $40,000.

Principal Investigator, "The role of vasopressin in learning and memory". National Institutes of Health (New Investigator Research Award) December 1983 - November 1986. Direct Costs $110,000.

Co-Investigator, "Dietary fat and the regulation of food intake in human subjects". National Institutes Health. December 1984 - November 1986. Direct Costs $78,000.

Principal Investigator, "The Role of oxytocin in normal cognitive functioning and mental illness". National Institutes of Health September 1981 - October 1983. Direct Costs $33,000.

TEACHING ACTIVITIES

Courses Taught

Nutritional Sciences 7030, Fall 2007-present, every semester; graduate seminar in which graduate students in Nutritional Sciences gain expertise in critically evaluating scientific articles and presenting them to a broad audience.

Faculty mentor, Biology Scholars Program (BSP), worked with a small group of students, to help them critically evaluate and then develop a presentation on a published article (The Biology Scholars Program is designed to increase the satisfaction, retention, and graduation of historically underrepresented students in the Biological Sciences), Fall 2010, Fall 2012.

Nutritional Sciences 401: Empirical Research, approximately 4 students each semester.

Psychology 470 - 471: Empirical Research and Psychology Honors Research, approximately 2 students each semester.

Biology 499, Empirical Research: approximately 6-8 students every semester

1983-present, every semester: Teach a weekly seminar for the students (undergraduate, graduate, and postdoctoral) conducting research under my supervision. This seminar entails critically evaluating scientific literature relevant to the ongoing research; approximately 12-15 students each semester.

12

NutrSci/Psych 361, "The Biopsychology of Normal and Abnormal Behavior" 1990-2006; developed and taught annually; an upper level undergraduate and graduate course; limited to juniors and seniors; enrollment limited to 85 students. A critical evaluation of biological factors thought to influence behavior and/or cognitive functioning. Biological, psychological, and societal influences will be integrated. Topics include: nutrition and behavior, psychiatric disorders, developmental exposure to environmental toxins and drugs of abuse; and biopsychology of learning, memory, intelligence, and related cognitive disorders.

NS 120, each spring (1997-2008) gave the lecture on “Biopsychology, Nutrition, and Health”

Toxicology 698: 1994-2001, taught the section on Neurotoxicology in this graduate toxicology course (J. Gillette, instructor); my section includes a historical perspective on the inclusion of neurotoxicological indices in risk assessment, approaches to assessing neurotoxicological effects in both animals and humans, and an overview of regulatory issues with an emphasis on neurotoxicological assessment.

1983 - 1989, taught the section on the biology of learning and memory in the "Biochemistry of Human Behavior". This section included various topics concerning the biochemistry and neuroanatomy of memory; the biochemistry of cognition and the implications for understanding mental illness; the biological bases of several mental retardation syndromes; approximately 120 students.

Developed and taught a seminar on the "Biochemistry of Mental Illness", to accompany Psychology 325, Introductory Psychopathology; Fall 1978; 15 students.

Invited Lectures in Other Courses at Cornell:

"Biological theories of depression and schizophrenia", Psych 101, 1980.

"Anorexic drugs and the control of body weight", Psych/NS 613, 1981.

"Biology of cognition", Psych 123, Fall 1985.

"Role of the cholinergic system in memory function", Psych 123, Fall 1986.

"Pathogenesis of the mental retardation in phenylketonuria", HDFS/NS 347, Spring 1987.

"Anorexia nervosa", NS 441, Fall 1987.

"Biochemistry of memory", Psych 123, Fall 1988.

"Eating disorders in adolescence", NS 222, Spring 1989.

"Nutrition and the behavior of children", Summer course in Pediatric Nutrition for Professional Nutritionists, 1990, 1991

"Pathogenesis in PKU: Implications for basic science and therapy", Summer course in Pediatric Nutrition for Professional Nutritionists, 1990, 1991

13

"Using Animal Models to Study Human Cognitive Pathology", Invited "Exploration" in Bio Sci 102, April, 1992 and April, 1993

“When asymptomatic does not mean safe: Lessons from an Animal Model of Childhood lead exposure”, Invited workshop, part of the “Johns Hopkins University Institute for the Academic Advancement of Youth 1998 Mathematics and Science Days: Mind and Brain: The Inner Frontier”, Cornell University, November 14, 1998.

Invited Lectures in Courses at other Institutions:

"Eating Disorders", invited lecture at Ithaca College, December, 1991.

Graduate Field Membership

Field of Psychology, 1989-presentField of Nutrition, 1993-presentField of Environmental Toxicology, 1996-present

Postdoctoral Fellows/Research Associates Supervised:

Dr. Shelley Drazen, 1993-1994Dr. Russ Morgan, 1994-1997Dr. Hugh Garavan, 1995-1997Dr. Linda Hermer-Vazquez, 1997-1999Dr. Tara White, 1998-2000Dr. Sheila Mihalick, 2000-2001Dr. Stephane Beaudin, 1998-2001, 2003-2009Dr. Kasia Kordas, 2004-2006 (co-supervised with Drs. Rick Canfield and Rebecca Stoltzfus)Dr. Jisoon Moon, 2006Dr. Brian Powers, 2009-2013Dr. Julie Nevins, 2016-present

Graduate Students Supervised

Major advisor

Currently supervised, (estimated completion date):Charlotte Bahnfleth, Ph.D. candidate in Nutritional Sciences (2019)Bailey Drewes, Ph.D. Candidate in Nutritional Sciences (2020)

Completed their degree:

Sharon A. Himmelstein. EFFECTS OF POSTNATAL HYPERPHENYLALANINEMIA ON COGNITIVE FUNCTION IN RATS. M.N.S., 1987

Janine Korahais Stasior. MASKING OF ATTENTIONAL DYSFUNCTION BY NUTRIENT RESTRICTION: THE EFFECT OF FOOD DEPRIVATION ON

14

DETECTION OF COGNITIVE DEFICITS IN RATS EXPOSED PRENATALLY TO ALCOHOL. M.S., 1990.

Mike Bunsey. EVIDENCE FOR MODULATION OF MNEMONIC AND ATTENTIONAL PROCESSES BY VASOPRESSIN AND NOREPINEPHRINE, Ph.D., 1991 (deceased)

Susan Alber. AN IN-DEPTH ANALYSIS OF LEAD EFFECTS IN A DELAYED ALTERNATION TASK: ASSESSMENT OF MNEMONIC EFFECTS, SIDE BIAS AND PROACTIVE INTERFERENCE, M.S., 1994

Julie Hilson. EFFECT OF LOW-LEVEL LEAD EXPOSURE ON REVERSAL LEARNING AND EXTRADIMENSIONAL SHIFTS IN THE RAT: EVIDENCE FOR INHIBITION DEFICITS NOT PERSEVERATION, M.S., 1996.

Rebecca Sawyer, "THE EFFECTS OF EARLY LEAD EXPOSURE ON REVERSAL AND EXTRADIMENSIONAL SHIFT LEARNING IN RODENTS: AN IN-DEPTH ANALYSIS OF RESPONSE PATTERNS IMPLICATES DEFICIENT ASSOCIATIVE PROCESSES", M.S., 1997.

Lori Driscoll, “EFFECTS OF EARLY LEAD EXPOSURE ON THE CHOLINERGIC AND GABAERGIC MODULATION OF ATTENTION AND REACTIVITY TO ERRORS”, Ph.D., Psychology, 2003

Mat Gendle, “PRENATAL COCAINE EXPOSURE AND ENDURING COGNITIVE DYSFUNCTION: EVIDENCE FROM AN ANIMAL MODEL”, Ph.D., Psychology, 2003

Caitlyn McNaughton, “ASSESSMENT OF SOCIAL COGNITION IN A MOUSE MODEL OF FRAGILE X SYNDROME”, M.S., Psychology, 2006.

Jisook Moon, “ASSESSMENT OF ATTENTIONAL FUNCTION IN MOUSE MODELS OF FRAGILE X SYNDROME AND DOWN SYNDROME” Ph.D., Nutritional Sciences, 2006.

Lorna Bayer, “ROLE OF CATECHOLAMINERGIC ALTERATIONS IN NORMAL AN ABNORMAL ATTENTIONAL FUNCTIONING”, Ph.D., Psychology, 2008

Tara Benedetto, “ROLE OF NORADRENERGIC ALTERATIONS IN THE ATTENTIONAL DYSFUNCTION PRODUCED BY PRENATAL COCAINE EXPOSURE”, Ph.D., Toxicology, 2008

Jessica Ash, “EFFECTS OF GENETIC AND DIETARY ALTERATIONS IN FOLATE STATUS ON ATTENTIONAL FUNCTION”; Ph.D., Psychology, 2011 (candidate in Psychology at SUNY-Albany (conducted her doctoral research in my lab)

Ramon Velazquez, “BENEFITS OF MATERNAL CHOLINE SUPPLEMENTATION IN A MOUSE MODEL OF DOWN SYNDROME: ELUCADATION OF UNDERLYING NEURAL MECHANISMS” Ph.D., Psychology, 2014

15

Co-Thesis Advisor:

Lauren Lissner. DIETARY CORRELATES OF HUMAN OBESITY: THE ROLE OF FAT INTAKE, Ph.D., 1987.

Anne Kendall Casella, LOW-FAT DIETS: A POTENTIAL THERAPY FOR WEIGHT REDUCTION, Ph.D., 1989.

Minor Member or Field-Appointed Member:

Currently supervised

Gina Mason, Ph.D. candidate in PsychologyCecilia Kwan, Ph.D. candidate in Nutritional SciencesEunice Awuah, Ph.D. candidate in Nutritional SciencesEdna Possolo, MS candidate in Nutritional SciencesDadirai Fundira, Ph.D. candidate in Nutritional Sciences

Completed their degreeJulia Noland, Ph.D., Psychology, 19??Ken Savitsky, Ph.D., Psychology, 19??Deborah Ash, Ph.D. Nutrition, 1999 Stephanie Weinstein, Ph.D. Nutrition, 1995Terry Horner, Ph.D., Nutrition, 1995Desi Kelleher, MS, Nutrition, 19??Tim Nolan, MS, Environmental Toxicology, 1999Terry Bunn, Ph.D., Immunology, 2001Sara Beaber, MS., Nutrition, 2002Emily Chase, Ph.D., Psychology, 2002Krysta Zanetti, Ph.D. Nutrition, 2003Andrea Azuma, MS, Nutrition, 2003Chueh (Angela) Chao, MS, Nutrition, 2003Anne-Marie Mayer, Ph.D., Nutrition, 2004Bruce Pan, Ph.D. Nutrition, 2006 Andrea Hsieh, Ph.D., Nutrition, 2006Maike Rahn, Ph.D. Nutrition 2007Nora Williams, Ph.D. Psychology, 2008Anna Pflaster, Ph.D., Nutritional Sciences, 2009 Emily Levitt, Ph.D. Nutritional Sciences, 2008Keriann Paul, Ph.D., Nutritional Sciences, 2009Jennifer Cowan, Ph.D. Nutritional Sciences, 2010Rosa Angelova, Ph.D. Nutritional Sciences, 2011Carly Pacanowski, Ph.D. Nutritional Sciences, 2013Isabelle Michaud-Letourneau, Ph.D., Nutritional Sciences, 2014Chelsea Helion, Ph.D., Psychology, 2014 Stacy Carling, Ph.D., Nutritional Sciences, 2015Cynthia Matare, Ph.D. Nutritional Sciences, 2015Elizabeth Fox, Ph.D., Nutritional Sciences, 2016Lua Wilkinson, Ph.D., Nutritional Sciences, 2016Elizabeth Fox, Nutritional Sciences, 2016

16

Invited Outside Examiner:

Nancy Lariviere, Ph.D., Psychology Department, SUNY-Binghamton, 1990.

Wei-jung Chen, Doctoral candidate, Psychology Department, SUNY-Binghamton, April, 1992.

James Stoehr, Doctoral Candidate, Department of Physiology, Dartmouth Medical School, April, 1993.

Charles Heyser, Doctoral Candidate, Department of Psychology and Program in Neurosciences, Binghamton University, December, 1993.

Cynthia Kern, Doctoral Candidate, Department of Environmental Toxicology, University of California at Santa Cruz, June 2009.

Visiting doctoral students:

Jose Barnabe, visiting doctoral student from Brazil (Dec. 1992 - Oct. 1994)Telma Braga Costa, visiting doctoral student from Brazil (Jan. 1994 - Jan. 1996)

Honors Students

Chris Hemmeter, IMPAIRED REDUNDANT LEARNING BY AMPHETAMINE ADMINISTRATION, magna cum laude, Department of Psychology, 1985.

David Kramer, INCREASED ATTENTIONAL SELECTIVITY BY A VASOPRESSIN FRAGMENT, summa cum laude, award for best Honors Thesis, Department of Psychology, 1986.

Brit Bertsche, A VASOPRESSIN FRAGMENT PRODUCES QUALITATIVELY EFFECTS ON MEMORY RETRIEVAL AS A FUNCTION OF THE RETENTION INTERVAL, Department of Neurobiology and Behavior, magna cum laude, 1987.

Nina Shapiro, MATERNAL ALCOHOL CONSUMPTION AND CIGARETTE SMOKING IN THE GASPE PENINSULA AND THE MAGDALEN ISLANDS, Biology and Society, cum laude, 1987.

Steve Ginsberg, ATTENTIONAL IMPAIRMENT IN RATS EXPOSED TO ALCOHOL PRENATALLY: LACK OF HYPOTHESIZED MASKING BY FOOD RESTRICTION, Department of Psychology, cum laude, 1988.

Joan Chun, FOOD RESTRICTION DOES NOT IMPAIR TRANSFER OF LEARNING: IMPLICATIONS FOR ANIMAL MODELS OF MENTAL RETARDATION, Department of Psychology, cum laude, 1990.

Jennifer Horne, IDAZOXAN PRODUCES QUALITATIVELY DIFFERENT EFFECTS ON MEMORY RETRIEVAL AS A FUNCTION OF THE RETENTION INTERVAL:

17

IMPLICATIONS FOR A MNEMONIC ROLE FOR NOREPINEPHRINE, Department of Psychology, magna cum laude, 1990.

Brian Saelens, THE EFFECTS OF CHRONIC LOW-LEVEL LEAD EXPOSURE ON ATTENTIONAL PROCESSES IN THE RAT, Psychology, magna cum laude, 1992.

Sachi Kimura, LOW-LEVEL DEVELOPMENTAL LEAD EXPOSURE: I. EFFECTS ON DELAYED ALTERNATION PERFORMANCE, Psychology, magna cum laude, 1993

Marsha Wittenk, ROLE OF DOPAMINE D2 RECEPTOR-ACTIVATION IN DISTRACTIBILITY AND RESPONSE INHIBITION, Psychology, magna cum laude, 1993

Melanie Hunt, LOW-LEVEL DEVELOPMENTAL LEAD EXPOSURE: II. EFFECTS ON VIGILANCE, RESPONSE INHIBITION AND DISTRACTIBILITY, Biological Sciences, cum laude, 1993

Tamara Clark, LOW-LEVEL DEVELOPMENTAL LEAD EXPOSURE: III. EFFECTS ON REVERSAL LEARNING, Human Ecology Honors Program, cum laude, 1993

Kelley Snow, EFFECTS OF A DOPAMINE (D1) AGONIST IN LEAD-EXPOSED AND CONTROL RATS: IMPLICATIONS FOR THE BIOLOGY OF ATTENTION AND FOR THE MECHANISM OF ACTION OF LEAD-INDUCED COGNITION DYSFUNCTION, Psychology, cum laude, 1994.

Hillary Raffman, EFFECTS OF DEVELOPMENTAL LEAD EXPOSURE ON LONG-TERM DECLARATIVE MEMORY IN RATS, Nutrition, cum laude, 1995.

Sujani Kakumanu, A COMPARISON OF THE ATTENTIONAL EFFECTS OF IDAZOXAN IN RATS EXPOSED TO COCAINE PRENATALLY AND CONTROLS: EVIDENCE FOR ENDURING CHANGES IN THE COEULEOCORTICAL NORADRENERGIC SYSTEM; Psychology, cum laude, 1996.

Christine Wu; A COMPARISON OF THE MNEMNONIC EFFECTS OF SCOPOLAMINE IN RATS EXPOSED TO LEAD DEVELOPMENTALLY AND CONTROLS: EVIDENCE FOR CHANGES IN THE CHOLINERGIC SYSTEM; Psychology, magna cum laude, 1996.

Julie Lorber, ASSESSMENT OF ENDURING ATTENTIONAL EFFECTS IN RATS EXPOSED TO COCAINE PRENATALLY, College Scholar, cum laude, 1996.

Alison Brown, EFFECT OF PRENATAL COCAINE EXPOSURE ON SENSITIVITY TO THE DOPAMINERGIC AGONIST SKF-81297: IMPLICATIONS FOR THE ROLE OF DOPAMINERGIC ACTIVITY IN ATTENTIONAL FUNCTION AND DYSFUNCTION, cum laude, Psychology, 1997.

Beth Kellerman, ROLE OF PREFRONTAL CATECHOLAMINES IN ATTENTIONAL FUNCTION; cum laude, Psychology, 1997.

Michael Higley, RECOVERY OF FUNCTION FOLLOWING EARLY LESIONS OF THE AMYGDALA IN THE RAT; magna cum laude, College Scholar, 1998.

18

Sara Gardiner, ENDURING EFFECTS OF EARLY POSTNATAL LEAD EXPOSURE ON PERFORMANCE IN A VIGILANCE TASK: MODULATION BY THE CHOLINERGIC SYSTEM, magna cum laude, Psychology, 1999

Jack Wu, LOW-LEVEL LEAD EXPOSURE IMPROVES THE PERFORMANCE OF RATS IN THE RADIAL ARM MAZE: IS MEMORY ALTERED OR SOMETHING ELSE?, magna cum laude, College Scholar, 2000

Anna Pflaster, THE EFFECTS OF EARLY POSTNATAL (Pb) EXPOSURE ON EXPLICIT MEMORY FUNCTION IN A RODENT MODEL, magna cum laude, Psychology, 2000

Vera Srakhao, LASTING ATTENTIONAL AND AFFECTIVE CHANGES PRODUCED BY EARLY LEAD EXPOSURE: ARE CHOLINERGIC CHANGES RESPONSIBLE?, Human Development, 2002

Jacqueline Demarchena, “EARLY LEAD EXPOSURE AND SELECTIVE ATTENTION: MEDIATION BY CHANGES IN THE CHOLINERGIC SYSTEM?”, Division of Nutritional Sciences, 2002.

Jenna Carroll, “ASSESSMENT OF SUSTAINED ATTENTION AND REACTIVITY TO ERRORS IN A MOUSE MODEL OF DOWN SYNDROME”, Division of Biological Sciences, magna cum laude, 2003.

Sara Verosky, “ASSESSMENT OF SELECTIVE ATTENTION AND REACTIVITY TO ERRORS IN A MOUSE MODEL OF FRAGILE X SYNDROME”, Department of Psychology, magna cum laude, 2004.

Marc Weiskopf, “IMPAIRED PERFORMANCE OF FMR1 KNOCKOUT MICE IN TWOSUSTAINED ATTENTION TASKS: EVIDENCE FOR DEFICIENT INHIBITORY CONTROL AND ADAPTABILITY TO CHANGE”, magna cum laude, Division of Biological Sciences, 2005

Kristie Ota, “ASSESSMENT OF TRANSFER OF LEARNING AND REVERSAL LEARNING IN THE FMR1 KNOCKOUT MOUSE MODEL OF FRAGILE X SYNDROME: EVIDENCE FOR IMPAIRED AROUSAL REGULATION”, Division of Biological Sciences, magna cum laude, Division of Biological Sciences, 2005

Shruti Gandhy, Division of Biological Sciences, 2007

May Chen, Division of Nutritional Sciences, 2007

Jin Hao, “ACUTE AND CHRONIC ADMINISTRATION OF THE ALPHA2-ADRENERGIC RECEPTOR AGONIST GUANFACINE IMPROVES SUSTAINED ATTENTION IN PRENATAL COCAINE-EXPOSED RATS” Division of Biological Sciences, 2008.

Adam Bisogni, “ASSESSMENT OF LEARNING AND ATTENTION IN FOLATE-DEFICIENT MICE: DISTINGUISHING THE EFFECTS OF DIETARY AND GENETIC INFLUENCES ON COGNITIVE FUNCTIONING”, Division of Nutritional Sciences, 2008

19

Christina Fiorenza, “THE EFFECTS OF ALTERED FOLATE METABOLISM ON COGNITIVE AND AFFECTIVE FUNCTIONING”, Division of Nutritional Sciences, 2009

Aneesha Badrinarayan, “ASSESSING THE MNEMONIC EFFECTS OF DIETARY AND GENETIC MANIPULATIONS OF FOLATE METABOLISM USING THE RADIAL ARM WATER MAZE” Division of Biological Sciences, 2009

Jenna MacDonald, “THE EFFECTS OF ALTERED FOLATE METABOLISM ON COGNITIVE FUNCTIONING UNDER CONDITIONS OF SURPRISING REWARD OMISSION”, Division of Nutritional Sciences, 2009

Clara Lee, “PRENATAL COCAINE EXPOSURE AND ITS EFFECTS ON THE LOCUS COERULEUS SYSTEM AND SUBSEQUENT ATTENTIONAL DYSFUNCTION”, Division of Nutritional Sciences, 2010.

Rian Yalamanchili, “THE COGNITIVE & NEURAL BENEFITS OF PERINATAL CHOLINE SUPPLEMENTATION IN A MOUSE MODEL OF DOWN SYNDROME AND ALZHEIMER’S DISEASE”, Psychology, magna cum laude, 2011

Linda Wu, Biology, 2012

Vidhya Kumar, Biology, 2012

Zoe Luscher, Biology and Society, 2013

Sujin Lee, Biological Sciences, 2013

Scott Kim, Nutritional Sciences, 2014

ADVISING ACTIVITIES

Advise undergraduates in Human Biology, Health and Society and Nutritional Sciences, 1990-present

Advise undergraduates in Psychology, 1995-present

Advise undergraduates in Biology and Society: Fall 2013- present

Advising Dean (Junior-Senior Team), College of Arts and Sciences, August –December 2013 (half-time during sabbatical leave)

Attend regular meetings of HCAN, Health careers advising network, Spring 2014- present

Freshman Biology advising: advised group of 8-9 incoming Biology freshman, Fall 2014- present

INVITED PRESENTATIONS

1. World Congress of Psychiatry, Vienna, Austria, Invited Lecture: "Vasopressin and memory", July 1983.

20

2. Fifth International Symposium on Models and Techniques of Cognitive Rehabilitation IV, Indianapolis, IN. Invited lecture: "Psychological determinants of cognitive processing: Animal models", April 1984.

3. Cornell University College of Veterinary Medicine, Invited Presentation to Perinatology Research Group, "Vasopressin and memory: A new role for an old hormone", January 1987.

4. SUNY-Binghamton, Center for the Study of Developmental Psychobiology, Colloquium, Binghamton, NY, "Using animal models to study the effects of early biological insults on adult cognitive functioning", March 1987.

5. Cornell University, Invited Speaker and Panel Participant, Seminar on the Use of Laboratory Animals in Research, sponsored by the Center for Research Animal Resources, Veterinary College, "Use of animal models to study human cognitive pathology", January, 1991.

6. University of California, San Diego, Invited Colloquium, "Biological influences on cognitive development: The use of animal models", Feb. 1991.

7. Cornell University, Department of Psychology, Invited Seminar, "Developmental influences on adult cognition: The use of animal models, March 1991.

8. Cornell University, Field of Nutrition, Invited Seminar: "Nutritional influences on cognitive development: The use of animal models", March 1991.

9. Cornell University, Field of Environmental Toxicology, Cornell University, Invited Seminar: "Behavioral teratology and toxicology: The importance of behavioral endpoints in risk assessment, but which ones?", April 1991.

10. Mead Johnson Research Center, Evansville, IND, "Scholars Seminar Series", Invited Seminar: "Cognitive functioning: A sensitive indicator of developmental brain damage", November, 1991.

11. Annual joint meeting of the Teratology Society and Behavioral Teratology Society, Workshop on "Assessment of Cognitive Functioning in Animal Models", Invited Organizer and Speaker, Boca Raton, FL, June, 1992.

12. Central Pennsylvania Lecture Series in Psychology, sponsored by Bucknell University and Susquehanna University, Invited Lecture: "Biological influences on cognitive development: The use of animal models", April 1992.

13. SUNY-Binghamton, Department of Psychology and Center for the Study of Developmental Psychobiology, Invited Colloquium, Binghamton, NY, "Animal models of developmental cognitive pathology", May, 1992.

14. Cornell Nutrition Research Update, Nutrition Inservice for Extension Agents, Invited Lecture: "Lead exposure and child development", May, 1992, Ithaca NY.

15. Annual meeting of the International Society for Developmental Psychobiology, Invited Speaker in a symposium on Transgenic Animal Models; talk entitled: "Animal models of developmental cognitive pathology”, October, 1992, Newport Beach, CA.

21

16. Cornell University, graduate seminar on Environmental Statistics, Invited Seminar: "Potential synergism of lead exposure and iron deficiency: Theoretical and statistical issues", December 1992, Ithaca NY.

17. Dartmouth College, Psychology Department, Invited Colloquium, "Modeling human cognitive pathology in animals", April 1993, Hanover, NH.

18. National Conference on the Link between Nutrition and Cognition, Invited Participant, June 27, 1994, Boston, MA.

19. University of Illinois College of Medicine, Department of Basic Sciences, Invited Colloquium, “Importance of cognitive assessments in behavioral toxicology: When does asymptomatic really mean safe?”, April 6, 1995, Peoria, Ill.

20. NIH, National Institute of Child Health and Human Development, Invited Speaker in a conference entitled “Animal Models for the Study of Mental Retardation”; title of talk: “Selecting Appropriate Behavioral Assessments for Animal Models of Cognitive Disorders”, September 21-22, 1995, Bethesda, MD.

21. Cornell University, Invited Speaker in a conference entitled, “Environmental Justice Colloquium: Building the New Paradigm for Iroquois-University Relationships”; title of talk: “Factors modifying the behavioral toxicity of lead”; December 2, 1995, Ithaca, NY.

22. NIH, National Institute of Child Health and Human Development, Invited Speaker at a conference entitled, “Cognitive Neuroscience and Neurodevelopmental Disorders: Conceptual and Methodological Challenges”; title of talk: “Animal models of neurodevelopmental disorders: Assessment of cognitive functioning”, March 22, 1996, Bethesda, MD.

23. University of Illinois at Champagne-Urbana, Department of Environmental Health Sciences, Invited Speaker, IES Distinguished Lecturer Series, "When asymptomatic does not mean safe: Assessment of the cognitive effects of low level lead exposure in an animal model", April 19, 1996, Urbana, IL.

24. Cornell University, Invited Seminar for the Field of Toxicology, “When asymptomatic does not mean safe: Assessment of the cognitive effects of low level lead exposure in an animal model", September 18, 1996, Ithaca, NY.

25. Conference entitled: “Superfund Basic Research Program: A Decade of Improving Health Through Multi-Disciplinary Research.” Title of presentation: “A rodent model of childhood lead exposure illuminates the nature of the cognitive deficit and provides a test of DMSA efficacy", February 25, 1997, Chapel Hill, NC.

26. Mount Sinai School of Medicine, Department of Community Medicine, Invited seminar entitled: “An Animal model of Childhood lead exposure: Progress in defining the cognitive profile and improving therapeutic intervention”, June 13, 1997, New York, NY.

27. Invited speaker (Plenary talk), Conference entitled, “International Conference on Mental Retardation: Genes, Brain, and Behavior”; talk entitled: “"What animals can tell us about developmental cognitive disorders -- if we know how to ask”; July 11, 1997, New York, NY.

22

28. Cornell University, Invited Seminar for the Field of Nutrition, “When asymptomatic does not mean safe: Studies of early lead exposure in an animal model”, March 5, 1998, Ithaca, NY.

29. University of Colorado Medical School, Invited seminar, entitled, "What animals can tell us about developmental cognitive disorders -- if we know how to ask”, February 8, 1999, Denver, CO.

30. Duke University, Invited speaker in a symposium, entitled, “"Lead: From Cellular Effects to Community Action", talk entitled, “A rodent model of early childhood lead exposure: Progress in defining the cognitive profile and improving therapeutic intervention”, Durham, NC, March 1, 1999.

31. Shriver Center, Division of Developmental Cognitive Neuroscience, Invited colloquium, entitled, “Prenatal cocaine exposure: the emerging cognitive profile”, Waltham, MA, March 26, 1999.

32. Behavioral Toxicology Society, Invited speaker and symposium participant; symposium entitled, “Attention as a Target of Intoxication: Insights and methods from studies of Drug Abuse”; talk entitled, “Impaired selective attention in animals exposed to cocaine in utero”, Research Triangle Park, NC, May 1, 1999.

33. Cornell University, EFNEP 30th Anniversary Celebration, Invited Speaker, workshop entitled, "When asymptomatic does not mean safe: Studies of early lead exposure in an animal model", June 16, 1999.

34. National Institute on Environmental Health Sciences (NIEHS) interagency workshop entitled, “The Role of Human Exposure Assessment in the Prevention of Environmental Disease”, Invited discussant for session, entitled, “Aggregate and Cumulative Exposure and Risk Assessment”, September 22-24, 1999, Rockville, MD.

35. The Salk Institute for Biological Studies, Invited Speaker in “The James S. McDonnell Foundation Panel Meeting on the Cognitive, Neural and Genetic Bases of Social Behavior”, Co-Organizers: U. Bellugi; D. Amaral, and J. Korenberg; November 14th - 15th, 1999, La Jolla CA.

36. Iowa State University of Science and Technology, Invited Speaker for a videoconference entitled, “How Nutrition Affects Cognition: Implications for Feeding Infants and Children”, April 27, 2000, Ames, Iowa.

37. National Institutes of Health, Invited participant in a conference entitled, “Early Childhood Neurobehavioral Assessment for the Differential Diagnosis of Fetal Alcohol Syndrome and Alcohol-related Neurodevelopmental Disorder.” March 8-10, 2000, Bethesda, MD.

38. Society of Toxicology, Invited Speaker and participant in a roundtable discussion entitled: “"Is chelation therapy effective for the treatment of low level lead poisoning?"; talk entitled: “Efficacy of succimer for alleviating cognitive impairment in a rodent model of early developmental lead exposure”; March 25-26, 2001; San Francisco, CA.

39. Behavioral Toxicology Society, Invited speaker and participant in a symposium entitled, “Cross-Species Neurobehavioral Testing and Statistical Applications Workshop”, talk entitled: A rodent model of prenatal cocaine exposure: Lasting effects on attention and reactivity to errors”, April 21-23, 2002, Research Triangle Park, NC.

40. Cornell University, Invited speaker in a panel discussion organized by “Women In Science and Engineering Resource”, April, 2002.

23

41. University of Michigan, Invited speaker and participant in a workshop entitled, “Exploring the Concept of Functional Isolation as a tool for understanding early nutritional insults”, Organized by Drs. Theodore Wachs and Betsy Lozoff, Ann Arbor, MI, May 2002.

42. Neurobehavioral Teratology Society, Invited speaker and symposium participant; symposium entitled: “Long-term effects of prenatal alcohol and cocaine exposure”, talk entitled: “Lasting changes in attention and reactivity to errors in an IV rodent model of prenatal cocaine exposure”, Scottsdale, AZ, June, 2002.

43. Tompkins County Health Department, Invited Speaker, talk entitled: “Childhood Lead Exposure: Insights from epidemiological studies and animal models”, Ithaca, NY, December 17, 2002.

44. Society for Behavioral Neuroscience, Invited speaker and symposium participant; symposium entitled: “Prenatal cocaine and attentional processes: Evidence for teratogenic effects on developing catecholamine systems”; talk entitled, “Prenatal cocaine exposure in a rodent model: Lasting effects on sustained and selective attention and reactivity to errors”, San Juan, Puerto Rico, April 2003.

45. Vanderbilt University, Invited speaker, Neuroscience Program, spring 2004.

46. Invited Speaker and workshop participant, Workshop sponsored by the NIH National Children's Study to review what is known about infections, inflammation, and neuropsychiatric diseases during fetal development, infancy, childhood and early adult life; May 20 & 21, 2004, Baltimore Md.

47. University of California at Santa Cruz, Invited Speaker, Department of Environmental Toxicology, colloquium series, Spring 2006 (invited).

48. Invited Speaker and symposium participant; symposium entitled: “Gender Differences in Effects of Prenatal Substance Exposure”; talk entitled: “Lasting cognitive and affective changes produced by prenatal cocaine exposure: selectivity of effects and influence of gender”; symposium organized by Margaret Bendersky and Michael Lewis, Institute for the Study of Child Development, New Brunswick, NJ, October 2006.

49. Invited Panelist and Participant, NIEHS Workshop to set priorities for Child Health; Research Triangle Park, NC, January 2007 (invited).

50. Invited co-Chair and Speaker, Workshop entitled, Advances in the Efficacy of Chelation Treatment to Alleviate Neurocognitive Effects of Lead and Autism Spectrum Disorders; Talk entitled: Succimer chelation improves learning, attention and arousal regulation in lead-exposed rats but produces lasting cognitive impairment in the absence of lead exposure; Society of Toxicology Annual Meeting, Charlotte, NC, March 2007.

51. Invited Speaker, “Multidisciplinary Workshop on Nutrition, Brain Development and Aging: Genetics, Epigenetics and Behavior”; talk entitled, “Perinatal choline administration produces lasting improvements in attention and arousal regulation in a mouse model of Down syndrome and Alzheimer’s Disease”, Kannapolis, North Carolina, May 12-14, 2008.

52. Symposium entitled, “Environmental Exposures to Pesticides and Metals: Impact on Neurodevelopment in Humans and Animal Models"; Invited Speaker, talk entitled, “Succimer chelation improves learning, attention and arousal regulation in lead-exposed rats but produces lasting cognitive

24

impairment in the absence of lead exposure”; Annual meeting of the Neurobehavioral Teratology Society, July 1, 2008, Monterey, CA.

53. McLean Hospital/Harvard Medical School, Belmont, MA, Invited Colloquium speaker, talk entitled, “Perinatal choline supplementation improves cognitive functioning in a mouse model of Down syndrome and Alzheimer’s Disease”, February 2, 2009.

54. Invited Speaker, Cornell University, Molecular and Human Nutrition Seminar series, talk entitled, “Perinatal choline supplementation improves cognitive functioning in a mouse model of Down syndrome: Implications for Alzheimer’s Disease and Aging-related cognitive decline”, April 9, 2009.

55. Invited Speaker, Center for Dementia Research, Nathan Kline Institute, & Departments of Psychiatry, Physiology, & Neuroscience, New York University, Langone Medical Center, Orangeburg, NY; talk entitled: “ Increasing maternal choline intake as a possible therapy for Down Syndrome and Alzheimer’s Disease? Evidence from the Ts65Dn mouse model of Down Syndrome”, April 28, 2011.

56. Invited Speaker, Symposium entitled “”; talk entited “Methods to test attention/executive function in rodents for regulatory studies”, annual meeting of the Neurobehavioral Teratology Society, AZ, June 25, 2013.

57. Invited seminar, Microbiology and Environmental Toxicology, University of California at Santa Cruz, Santa Cruz, CA, Fall 2013 (invited).

58. Invited seminar, NIEHS Training Program in Environmental Health Sciences, University of California at Davis, Davis, California, Fall 2013 (invited).

59. Invited speaker, Department of Psychology, Colby College, Fall 2013 (invited).

60. Invited Speaker, NBTS, 2014 – Tom Burbacher’s invitation (invited).

61. Invited Speaker, Department of Psychology, Colby College, Spring 2015 (invited)

62. Invited Speaker, The Trisomy 21 Research Society, Paris, France; talk entitled: "The effects of maternal choline supplementation in the Ts65Dn mouse model"; June the 4-7, 2015. (invited)

63. Invited Speaker, Down Syndrome Innovations Conference, Arkansas Children's Hospital, Little Rock, Arkansas, September 11-12, 2015.

64. Invited plenary speaker; workshop entitled, “Nutrition and the Developing Mind”, Center for Mind and Brain, UC Davis, October 15-17, 2015. (invited)

65. Invited speaker, UNC-Nutrition Research Institute, Kannapolis, NC, Fall, 2015, spring 2016 (invited)

PUBLICATIONS (articles in refereed journals and book chapters)

1. Blundell JE, Strupp BJ, Latham CJ. Pharmacological manipulation of hoarding: Further analysis of amphetamine isomers and pimozide. Phys. Psych. 5(4):462-468, 1977.

25

2. Levitsky DA, Strupp BJ, Lupoli J. Tolerance to anorectic drugs: Pharmacological or artifactual. Pharmacol. Biochem. Behav. 14:661-667, 1981.

3. Levitsky DA, Strupp BJ. Malnutrition and tests of brain function. In: Miller S, ed. Nutrition and Behavior. Franklin Institute Press, 1982.

4. Levitsky DA, Strupp BJ. Behavioral control of energy expenditure. In: Cioffi LA, et al., eds. The Body Weight Regulatory System: Normal and Disturbed Mechanisms. New York: Raven Press, 1982.

5. Weingartner H, Gold PW, Hoban C, Smallberg S, Strupp BJ. Effects of neuropeptides on cognition in unimpaired subjects: theoretical and methodological implications. In: Ordy F, Sladek L, Reisberg B, eds. Neuropeptide and Hormonal Modulation of Brain Function and Homeostasis. New York: Raven Press, 1982.

6. Levitsky DA, Strupp BJ. Reinforcing health care. Contemp. Psychol. 27(2):149-150, 1982.

7. Strupp BJ, Levitsky DA. Early brain insult and cognition: A comparison of early malnutrition and hypothyroidism. Develop. Psychobiol. 16(6): 535-549, 1983.

8. Strupp BJ, Levitsky DA. Social transmission of food preferences. J. Comp. Psych. 98(3):257-266, 1984.

9. Strupp BJ, Levitsky DA, Blumstein, L. PKU and models of mental retardation. Develop. Psychobiol 17(2):109-120, 1984.

10. Gold PW, Rubinow D, Post RM, Kaye W, Strupp BJ, Fisher D, Artman A, Goodwin FK. Presence of oxytocin in human cerebrospinal fluid: comparison of levels found in normal controls and patients with affective illness and anorexia nervosa. Am. J. Psychiat., 1984.

11. Strupp BJ, Weingartner H, Goodwin FK, Gold PW. Neurohypophyseal hormones and cognition. Pharmacol. Ther. 23(2):179-191, 1984.

12. Strupp BJ, Weingartner H. Vasopressin and cognition: an analysis and perspective. Drug Develop. Res. 4(5):501-516, 1984.

13. Weingartner H, Strupp BJ. Cognitive analysis of neuropharmacological treatments. Drug Develop. Res. 4(5):577-589, 1984.

14. Levitsky DA, Strupp BJ. Functional isolation in rats. In: Brozek J, Schurch B, eds. Malnutri tion and Behavior: Critical Assessment of Key Issues. Lausanne, Switzerland: Nestle Foundation, 1984;411-420.

15. Strupp BJ, Levitsky DA. A mnemonic role for vasopressin: The evidence for and against. Neurosci. Biobehav. Rev. 9:399-411, 1985.

16. Strupp BJ, Weingartner H. Behavioral effects of vasopressin treatment: cognitive implications. In: Pichot P, et al., eds. Psychiatry: The State of the Art. New York: Plenum Press, New York, 1985.

17. Levitsky DA, Strupp BJ. Nutrition and the behavior of children. In: Walker WA, Watkins J, eds. Nutrition and Pediatrics - Basic Science and Clinical Application . Boston: Little Brown, 1985.

26

18. Levitsky DA, Strupp BJ. Direct and indirect thermogenic effects of anorectic drugs. In: Advances in Nutritional Research, 7:187-201, 1985.

19. Weingartner H, Strupp BJ. Specificity of cognitive changes following psychotropic drug treatment. In: Pichot P, et al., eds. Psychiatry: The State of the Art. New York: Plenum Press, 1985.

20. Strupp BJ, Weingartner H, Kaye W, Gwirtsman H. Cognitive processing in anorexia nervosa: a disturbance in automatic information processing. Neuropsychobiology 15:89-94, 1986.

21. Levitsky DA, Schuster J, Stallone D, Strupp BJ. Modulation of the thermogenic effect of nutrients by fenfluramine. Int. J. Obesity, 10:169-174, 1986.

22. Levitsky DA, Strupp BJ. Nutritional deficiencies and cognition. In: Cognitive Testing Methodology. National Academy Press, 1986;81-100.

23. Lissner L, Levitsky DA, Strupp BJ, Kalkwarf HJ, Roe DA. Dietary fat and the regulation of energy intake in human subjects. Am. J. Clin. Nutr. 46:886-892, 1987.

24. Lissner L, Stevens J, Rasmussen K, Levitsky DA, Strupp BJ. Variation in ad libitum energy intake across the menstrual cycle: Implications for food intake research. Am. J. Clin. Nutr. 48:956-962, 1988.

25. Strupp BJ, Korahais J, Levitsky DA, Ginsberg LS. Attentional impairment in rats exposed to alcohol prenatally: Lack of hypothesized masking by food deprivation. Ann. New York Acad. Sci. 562:380-382, 1989.

26. Lissner L, Habicht J-P, Strupp BJ, Levitsky DA, Haas J, Roe DA. Body composition and energy intake: Do overweight women overeat and underreport? Am. J. Clin. Nutr. 49:320-325, 1989.

27. Strupp BJ. Improvement of memory by a vasopressin fragment: Importance of individual differences in mnemonic function. Behav. Neurosci. 103:743-754, 1989.

28. Bunsey M, Kramer D, Kesler M, Strupp BJ. A vasopressin metabolite increases attentional selectivity. Behav. Neurosci. 104:277-287, 1990.

29. Strupp BJ, Bunsey M, Bertsche B, Levitsky DA, Kesler M. Enhancement and impairment of memory retrieval by a vasopressin metabolite: An interaction with the accessibility of the memory. Behav. Neurosci. 104:268-276, 1990.

30. Bunsey M, Strupp BJ. A vasopressin metabolite produces qualitatively different effects on memory retrieval depending on the accessibility of the memory. Behav. Neural Biol. 53:346-355, 1990.

31. Strupp BJ, Himmelstein S, Bunsey M, Levitsky DA, Kesler M. Cognitive profile of rats exposed to lactational hyperphenylalaninemia: Correspondence with Human Mental Retardation. Develop. Psychobiol. 23:195-214, 1990.

32. Strupp BJ, Levitsky DA. An animal model of retarded cognitive development. In: Collier CR, Lipsett L, eds. Advances in Infancy Research, Vol. 6. Norwood, NJ: ABLEX Publishing Corporation, 1990:149-186.

27

33. Kendall A, Levitsky DA, Strupp BJ, Lissner, L. Weight loss on a low fat diet: Consequence of the imprecision of the control of food intake in humans. Am. J. Clin. Nutr. 53:1124-29, 1991.

34. Strupp BJ, Bunsey M, Levitsky DA, Kesler M. Time-dependent effects of post-trial amphetamine treatment in rats: Evidence for enhanced storage of representational memory. Behav. Neural Biol. 56:62-76, 1991.

35. Levitsky DA, StruppBJ. Nutrition and the behavior of children. In: Suskind RM, ed. Textbook of Pediatric Nutrition, 2nd Edition. New York: Raven Press, 1992.

36. Levitsky DA, Strupp BJ. Imprecise control of food intake on low-fat diets. In: Fernstrom JD, Miller GD, eds. Appetite and Body Weight Regulation: Sugar, Fat, and Macronutrient Substitutes. Boca Raton, FL: CRC Press Inc., 1993:179-190.

37. Strupp BJ, Bunsey M, Levitsky DA, Hamberger K. Deficient cumulative learning: An animal model of retarded cognitive development. Neurotoxicol. Teratol. 16(1):71-79, 1994.

38. Strupp BJ, Levitsky DA. Enduring cognitive effects of early malnutrition: A theoretical re-appraisal. J. Nutr.125:2221S-2232S, 1995.

39. Levitsky DA, Strupp BJ. Malnutrition and the brain; Changing concepts, changing concerns. J. Nutr. 125:2233S-2243S, 1995.

40. Bunsey MD, Strupp BJ. Specific effects of Idazoxan in a distraction task: Evidence that endogenous norepinephrine plays a role in selective attention. Behav. Neurosci. 109(5):903-911, 1995.

41. Alber SA, Strupp BJ. An in-depth analysis of lead effects in a delayed spatial alternation task: Assessment of mnemonic effects, side bias and proactive interference. Neurotoxicol. Teratol. 18(1):3-15, 1996.

42. Almeida NG, Levitsky DA, Strupp BJ. Enhanced thermogenesis during recovery from diet-induced weight gain in the rat. Am. J. Physiol. 271:R1380-R1387, 1996.

43. Pollitt E, Golub M, Gorman K, Grantham-McGregor S, Levitsky D, Schurch B, Strupp B, Wachs T. A reconceptualization of the effects of undernutrition on children’s biological, psychosocial, and behavioral development. Social Policy Report X(5):1-22, 1996.

44. Hilson J, Strupp BJ. Analyses of response patterns clarify lead effects in olfactory reversal and extra-dimensional shift tasks: Assessment of inhibitory control, associative ability, and memory. Behav. Neurosci. 111(3):532-542, 1997.

45. Strupp BJ, Diamond A. Assessing cognitive function in animal models of mental retardation. Mental Retard. Develop. Dis. Res. Rev. 2(4):216-226, 1996.

46. Smith D, Bayer LE, Strupp BJ. Efficacy of Succimer Chelation for Reducing Brain Pb Levels in a Rodent Model. Environ. Res. 78:168-176, 1998.

47. Su C-L, Austic RE, Strupp BJ, Levitsky, DA. Improved model of maternal phenylketonuria in rats by use of lower dietary concentrations of methylphenylalanine and l-phenylalanine in a semipurified diet. Nutr. Res. 18(6): 989-1002, 1998.

28

48. Austic RE, Su C-L, Strupp BJ, Levitsky DA. Effects of dietary mixtures of amino acids on fetal growth and maternal fetal amino acid pools in experimental maternal phenylketonuria. Am. J. Clin. Nutr. 69(4): 687-696, 1999.

49. Garavan H, Morgan RE, Hermer-Vazquez L, Levitsky DA, Strupp BJ. Enduring effects of early lead exposure: Evidence for a specific deficit in associative ability. Neurotoxicol. Teratol., 22(2):151-164, 2000.

50. Bushnell PJ, Marrocco RT, Strupp BJ, Sarter MF, Levin ED, Warburton DM. Attention as a Target of Intoxication: Insights and Methods from Studies of Drug Abuse. Neurotoxicology and Teratology, 22(2): 487-502, 2000.

52. Morgan RE, Levitsky DA, Strupp BJ. Effects of chronic low-level lead exposure on learning and reaction time in a visual discrimination task. Neurotoxicology and Teratology, 22(3): 337-345, 2000.

53. Garavan H, Morgan RE, Mactutus CF, Levitsky DA, Booze RM, Strupp BJ. Prenatal cocaine exposure impairs selective attention: evidence from serial reversal and extradimensional shift tasks. Behavioral Neuroscience 114(4):725-738, 2000.

54. Bayer LE, Brown A, Mactutus CF, Booze RM, Strupp BJ. Prenatal cocaine exposure increases sensitivity to the attentional effects of the dopamine D1 agonist SKF81297. J. Neurosci. 20(23):8902-8908, 2000.

55. Higley M., Hermer-Vazquez L., Levitsky D.A., Strupp BJ. Recovery of associative function following early amgydala lesions. Behavioral Neuroscience, 115, 154-164, 2001.

56. Widholm JJ, Clarkson GB, Strupp BJ, Crofton KM, Seegal RF, Schantz SL. Spatial Reversal Learning in Aroclor 1254 or Dioxin-exposed Rats: Sex-Specific Deficits in Associative Ability and Inhibitory Control in Aroclor 1254-Exposed Rats, Toxicology and Applied Pharmacology, 174, 188-198, 2001.

57. Morgan RE, Garavan H, Smith E, Driscoll LL, Levitsky DA, Strupp BJ. Enduring effects of early lead (Pb) exposure on sustained attention, response initiation, and reactivity to errors. Neurotoxicology and Teratology, 23(6): 519-532, 2001.

58. Bayer LE, Kakumanu S, Mactutus CF, Booze RM, Strupp BJ. Increased sensitivity to idazoxan in rats exposed to cocaine in utero: Evidence for enduring effects on catecholaminergic systems underlying attention. Behavioural Brain Research, 133(2):185-196, 2002.

59. Morgan RE, Garavan H, Mactutus CF, Levitsky DA, Booze RM, Strupp BJ. Enduring effects of prenatal cocaine exposure on attentional control and reactivity to errors. Behavioral Neuroscience, 116(4):624-33, 2002.

60. Widholm JJ, Seo B-W, Strupp BJ, Seegal RF, Schantz SL. Effects of Perinatal Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) on Spatial and Visual Reversal Learning in Rats. Neurotoxicology and Teratology, 2003 Jul-Aug; 25(4): 459-71.

61. Gendle MH, Strawderman M, Mactutus CF, Levitsky DA, Booze RM, and Strupp BJ. Alterations in reactivity to errors and sustained attention in an animal model of prenatal cocaine exposure.

29

Developmental Brain Research, 147, 2003, 85-96 (Special Edition on Drugs of Abuse, invited contribution).

62. Stangle, DE., Strawderman M, Smith D., Kuypers M, & Strupp BJ. Repeated regimens of Succimer show different treatment efficacy in brain versus blood in a rodent model of childhood lead exposure, Environmental Health Perspectives, 112:302-308, 2004 (online, Oct. 31, 2003).

63. Gendle MH, White TL, Strawderman M, Mactutus CF, Booze RM, Levitsky DA, and Strupp BJ. Enduring Effects of Prenatal Cocaine Exposure on Selective Attention and Reactivity to Errors: Evidence from an Animal Model. Behavioral Neuroscience, 118(2): 290-297, 2004.

64. Gendle MH, Strawderman M, Mactutus CF, Levitsky DA, Booze RM, and Strupp BJ. Prenatal cocaine exposure does not alter spatial working memory in adult rats. Neurotoxicology and Teratology, 26(2): 319-329, 2004.

65. Driscoll LL; Carroll JC; Moon J-S; Crnic LS, Levitsky DA; Strupp BJ. Impaired Sustained attention and error-induced stereotypy in the aged Ts65Dn mouse, a mouse model of Down syndrome and Alzheimer disease. Behavioral Neuroscience, 2004, 118 (6): 1196–1205.

66. Foltz TL, Snow DM, Strupp BJ, Booze RM, and Mactutus CF. Prenatal intravenous cocaine and the heart rate-orienting response: a dose-response study. International Journal of Developmental Neuroscience 22(5-6):285-96, 2004.

67. Levitsky DA, Obarzanek E, Mrdjenovic G, and Strupp BJ. Imprecise Control of Energy Intake: Absence of a Reduction in Food Intake following Overfeeding in Young Adults. Physiol Behav. 2005 Apr 13;84(5):669-75.

68. Strupp BJ & Beaudin S. Assessing the neurobehavioral effects of early toxicant exposure: A perspective from animal research. In: Bellinger D (ed.), Human Developmental Neurotoxicology, New York, NY: Taylor & Francis Group, 2006: 415-445.

69. Booze RM, Wallace DR, Silvers JM, Strupp BJ, and Mactutus CF. Prenatal cocaine alters alpha2 receptor expression in adolescent rats. BMC Neuroscience 2006, 7:33.

70. Moon J, Beaudin AE, Crnic L, Levitsky, DA, Strupp BJ. Impairments in inhibitory control, arousal regulation and sustained attention in the fmr1 mouse model of Fragile X syndrome. Behavioral Neuroscience, 2006 Dec;120(6):1367-79.

71. Grantham-McGregor S, Cheung YB, Cueto S, Glewwe P, Richter L, Strupp B; International Child Development Steering Group. Developmental potential in the first 5 years for children in developing countries. Lancet. 2007 Jan; 369(9555):60-70.

72. Stangle DE, Smith D, Beaudin SA, Strawderman MS, Levitsky DA, and Strupp BJ. Succimer chelation improves cognition and arousal regulation in lead-exposed rats but produces lasting cognitive impairment in the absence of lead exposure. Environ Health Perspect. 2007 Feb;115(2):201-9. Epub 2006 Oct 30.

73. Beaudin SA, Stangle DE., Strawderman M, Levitsky, DA, and Strupp BJ. Succimer chelation normalizes emotion regulation in rats exposed to lead early in life: Evidence from an olfactory

30

conditional discrimination task with periodic omission of an expected reward. Neurotox. Teratol 29: 188–202 (2007) [Online 12 November 2006].

74. Ferris MJ, Mactutus CF, Silvers JM, Hasselrot U, Beaudin SA, Strupp BJ, Booze RM. Sex mediates dopamine and adrenergic receptor expression in adult rats exposed prenatally to cocaine. Int J Dev Neurosci. 2007 Nov;25(7):445-54. Epub 2007 Sep 4.

75. McNaughton, C. H., Moon, J., Strawderman, M. S., Maclean K. N., Evans, J., Strupp, B. J. (2008). Evidence for social anxiety and impaired social cognition in a mouse model of Fragile X syndrome. Behav. Neurosci, 2008 Apr;122(2):293-300.

76. Moon J, Ota KT, Driscoll LL, Levitsky DA, Strupp BJ (2008). A mouse model of Fragile X syndrome exhibits heightened arousal and/or emotion following errors or reversal of contingencies. Developmental Psychobiology, 2008 Jul;50(5):473-85.

77. Bushnell PJ, Strupp BJ. Assessing Attention in Rodents. In: Methods of behavioral analysis in neuroscience (2nd ed.). Buccafusco, Jerry J. (Ed.); Boca Raton, FL, US: CRC Press, 2009. pp. 119-143.

78. Moon J., Chen M, Gandhy SU, Strawderman M, Levitsky DA, Maclean KN, and Strupp BJ. Perinatal choline supplementation improves cognitive functioning and emotion regulation in the Ts65Dn mouse model of Down syndrome. Behavioral Neuroscience, 2010, 124 (3):346–361.

79. Beaudin SA, Gendle MH, Strupp BJ. Lasting attentional and affective dysfunction produced by prenatal cocaine exposure in a rodent model: Gender effects. Chapter 4 in: Gender Differences in Effects of Prenatal Substance Exposure", Lisa Kestler and Michael Lewis (Eds), Washington, D.C., American Psychological Association, 2011.

80. Bae SH, Lee HS, Kang MS, Strupp BJ, Chopp M, Moon J. The Levels of Pro-Inflammatory Factors Are Significantly Decreased in Cerebral Palsy Patients Following an Allogeneic Umbilical Cord Blood Cell Transplant.  Int J Stem Cells. 2012 May;5(1):31-38.

81. Field MS, Shields KS, Abarinov EV, Malysheva OV, Allen RH, Stabler SP, Ash JA, Strupp BJ, Stover PJ, Caudill MA. Reduced MTHFD1 activity in mice perturbs folate and choline dependent one-carbon metabolism as well as transsulfuration. J. Nutrition, 2013 Jan;143(1):41-5. doi: 10.3945/jn.112.169821. Epub 2012 Nov 28. PMCID: PMC3521460

82. Ash JA, Jiang X, Malysheva OV, Fiorenza CG, Bisogni AJ, Levitsky DA, Strawderman MS, Caudill MA, Stover PJ, Strupp BJ. Dietary and genetic manipulations of folate metabolism differentially affect prefrontal cortical functions in mice. Neurotoxicol Teratol. 2013 Jul-Aug; 38:79-91. doi: 10.1016/j.ntt.2013.05.002. Epub 2013 May 15. PMID: 23684804

83. Velazquez R., Kelley CM, Powers BE, Ash JA, Ginsberg SD, Mufson EJ, and Strupp BJ: Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome, Neurobiol. Dis. 58 (2013) 92–101. PMID: 23643842

84. Kelley CM, Powers BE, Velazquez R, Ash JA, Ginsberg SD, Strupp BJ, Mufson EJ (2013). Sex differences in cholinergic basal forebrain in the Ts65Dn mouse model of Down syndrome and Alzheimer’s disease, Brain Pathology doi:10.1111/bpa.12073. PMID: 23802663

31

85. Smith D, Strupp BJ. The Scientific Basis for Chelation: Animal Studies and Lead Chelation (2013). J Med Toxicol. 2013 Dec;9(4):326-38. doi: 10.1007/s13181-013-0339-2. PMCID: 3846979

86. Kelley CM, Powers BE, Velazquez R, Ash JA, Ginsberg SD, Strupp BJ, Mufson EJ (2013). Perinatal choline supplementation differentially alters the basal forebrain cholinergic system of young-adult Ts65Dn and disomic mice. J Comp Neurol. 2014 Apr 15;522(6):1390-410. PMCID: 3959592

87. Yan, J., Ginsberg, S.D., Powers, B., Alldred, M.J., Saltzman, A., Strupp, B.J., and Caudill, M.A.: Maternal choline supplementation programs greater activity of the phosphatidylethanolamine N-methyltransferase (PEMT) pathway in adult Ts65Dn trisomic mice. FASEB J., 28: 4312-423, 2014. PMID: 24963152.

88. Ash A, Velazquez R, Kelley CM, Powers BE, Strawderman M, Ginsberg SD, Mufson EJ, Strupp BJ. Maternal choline supplementation improves spatial mapping and increases number and size of basal forebrain cholinergic neurons in aged Ts65Dn mice; Neurobiology of Disease, 2014 Oct;70:32-42. doi: 10.1016/j.nbd.2014.06.001. Epub 2014 Jun 14.

89. Driscoll LL & Strupp BJ. Assessment of attention and inhibitory control in rodent developmental neurotoxicity studies. Neurotoxicology and Teratology, 2015 Nov-Dec;52(Pt A):78-87. doi: 10.1016/j.ntt.2014.09.001. Epub 2014 Sep 16., PMID:25224214

90. Beaudin SA, Strupp BJ, Lasley SM, Fornal CA, Mandal S, Smith DR. Oral methylphenidate alleviates the fine motor dysfunction caused by chronic postnatal manganese exposure. Toxicological Sciences, 2015 Apr;144(2):318-27. doi: 10.1093/toxsci/kfv007. Epub 2015 Jan 19. PMID: 25601986

91. Powers, B.E., Velazquez, R., Kelley, C.M., Ash, J.A., Strawderman, M.S., Alldred, M.J., Ginsberg, S.D., Mufson, E.J., and Strupp, B.J.: Attentional function and basal forebrain cholinergic neuron morphology during aging in the Ts65Dn mouse model of Down syndrome. Brain Struct. Funct., 2015 Dec 30. [Epub ahead of print]. December 2016, Volume 221, Issue   9 , pp 4337–4352. PMID: 26719290. NIHMSID #753351.

92. Kelley, C.M., Ash, J.A., Powers, B.E., Velazquez, R., Alldred, M.J., Ikonomovic, M.D., Ginsberg, S.D., Strupp, B.J., and Mufson, E.J.: Effects of maternal choline supplementation on the septohippocampal cholinergic system in the Ts65Dn mouse model of Down syndrome. Curr Alzheimer Res., 13: 84-96, 2016. PMID: 26391046. PMCID: PMC4733527.

93. Strupp, B.J., Powers, B.E., Velazquez, R., Ash, J.A., Kelley, C.M., Alldred, M.J., Strawderman, M.S., Caudill, M.A., Mufson, E.J., and Ginsberg, S.D.: Maternal choline supplementation: A potential prenatal treatment for Down syndrome and Alzheimer’s disease. Curr Alzheimer Res. 13: 97-106, 2016. PMID: 26391045. PMCID: PMC4733524.

94. Beaudin SA, Strupp BJ, Strawderman M, Smith DR, Early Postnatal Manganese Exposure Causes Lasting Impairment of Selective and Focused Attention and Arousal Regulation in Adult Rats. Environmental Health Perspectives, 2016 Jul 6. [Epub ahead of print]; PMID: 27384154

 95. Venkatramanan S, Armata IE, Strupp BJ, Finkelstein JL. Vitamin B-12 and Cognition in Children,

Advances in Nutrition, 2016 Sep 15;7(5):879-88. doi: 10.3945/an.115.012021. PMID: 27633104.

96. Powers BE, Kelley CM, Velazquez R, Ash A, Strawderman M, Ginsberg SD, Mufson EJ, Strupp BJ. Maternal choline supplementation in a mouse model of Down syndrome: Assessment of attentional

32

benefits in relation to nucleus basalis/substantia innominata neuron morphology. Neuroscience, in press.

97. Beaudin SA, Strupp BJ, Strawderman M, Smith DR, Methylphenidate alleviates manganese-induced impulsivity but not distractibility. Neurotoxicology and Teratology; in press;

98. Caudill MA, Canfield RL, Muscalu L, Strupp BJ. Effect of prenatal choline supplementation on measures of infant cognition: a randomized, double-blind, controlled feeding study. Lancet, Submitted for publication.

99. Powers BE, Santiago N, Kim, S, Strupp BJ. Rapid forgetting of social learning in the Ts65Dn mouse model of Down Syndrome: further evidence for hippocampal dysfunction. In preparation

100. Moon J., Maclean KN., Strawderman MS, Levitsky DA, Strupp B J. Lasting attentional dysfunction and autistic-like features in a mouse model of Fragile X syndrome. Submitted for publication.

101. Kelley CM, Powers BE, Velazquez R, Ash JA, Ginsberg SD, Strupp BJ, Mufson EJ. (In preparation). Morphologic and transcriptomic alterations in nucleus basalis of Meynert and horizontal diagonal band cholinergic neurons of perinatal choline-supplemented segmentally trisomic (Ts65Dn) sixteen month old mice.

102. Kelley CM, Powers BE, Velazquez R, Ash JA, Ginsberg SD, Strupp BJ, Mufson EJ. (In preparation). Alterations in morphology of septodiagonal band cholinergic neurons and cholinergic innervation of cholinoceptive regions of perinatal choline-supplemented segmentally trisomic (Ts65Dn) seventeen month old mice.

103. Kelley CM, Powers BE, Velazquez R, Ash JA, Ginsberg SD, Strupp BJ, Mufson EJ. (in preparation). Alterations in subgranular neurogenesis and hippocampal cholinergic innervation of perinatal choline-supplemented sixteen month old Ts65Dn mouse model of Down syndrome. In preparation.

Articles in Other Publications:

Levitsky DA, Strupp BJ. Exercise and weight control. Professional Perspectives, July/Aug. 1984:1-4.